NanoViricides, Inc. Files Q3 2025 10-Q
Ticker: NNVC · Form: 10-Q · Filed: May 15, 2025 · CIK: 1379006
| Field | Detail |
|---|---|
| Company | Nanoviricides, Inc. (NNVC) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceutical
Related Tickers: NVCR
TL;DR
NVCR Q3 2025 10-Q filed. Financials updated.
AI Summary
NanoViricides, Inc. filed its 10-Q for the period ending March 31, 2025. The company, incorporated in Nevada, operates in the pharmaceutical preparations sector. Key financial data points such as retained earnings and additional paid-in capital are reported as of various dates throughout 2023, 2024, and March 31, 2025.
Why It Matters
This filing provides investors with an update on NanoViricides' financial position and performance for the third quarter of fiscal year 2025, crucial for assessing the company's health and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, NanoViricides faces inherent risks related to drug development, regulatory approval, and market competition, which are typical for the sector.
Key Numbers
- 2025-03-31 — Balance Sheet Date (Represents the end of the reporting period for the financial statements.)
- 2024-03-31 — Prior Year Balance Sheet Date (Provides a comparative point for financial analysis.)
- 2025-01-01 — Quarter Start Date (Beginning of the current reporting quarter.)
- 2025-03-31 — Quarter End Date (End of the current reporting quarter.)
- 2024-07-01 — Year-to-Date Start Date (Beginning of the fiscal year for year-to-date calculations.)
Key Players & Entities
- NANOVIRICIDES, INC. (company) — Filer
- 20250331 (date) — Period of Report
- 20250515 (date) — Filed as of Date
- 0001379006 (company) — Central Index Key
- 2834 (industry_code) — Standard Industrial Classification
- NV (state) — State of Incorporation
- 0630 (date) — Fiscal Year End
- 001-36081 (company) — SEC File Number
FAQ
What is the primary business of NanoViricides, Inc.?
NanoViricides, Inc. operates in the Pharmaceutical Preparations sector, with the Standard Industrial Classification code 2834.
For what period is this 10-Q filing?
This 10-Q filing is for the period ending March 31, 2025.
When was this 10-Q filing submitted?
The filing was submitted on May 15, 2025.
In which state was NanoViricides, Inc. incorporated?
NanoViricides, Inc. was incorporated in Nevada (NV).
What is the company's fiscal year end?
The company's fiscal year ends on June 30 (0630).
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding NANOVIRICIDES, INC. (NNVC).